Mutation of the tau-phosphorylating enzyme glycogen synthase kinase (GSK3B) has been postulated as a possible cause of dementia. Now, a US study has identified an association between a single ...

Importantly, these experiments widened the utility of GSK3B inhibitors, which were originally developed as anti-diabetic agents, to use in cancer therapy. Thus, such a systems approach to p53 ...